Eli Lilly and Company (LLY) is Drawing Interest from Investors: Key Information You Need to Know

Eli Lilly (LLY): Recent Performance and Outlook

Eli Lilly (LLY) has recently become a focal point for many investors, prompting a closer look at the factors that could influence its short-term trajectory.

In the past month, shares of Eli Lilly have declined by 2.5%, underperforming both the Zacks S&P 500 composite, which fell 1.3%, and the Zacks Large Cap Pharmaceuticals sector, which slipped 0.1%. This raises the question: what might be next for Lilly’s stock?

While news headlines or speculation can cause quick shifts in a stock’s price, long-term investment decisions are ultimately shaped by fundamental business factors.

Earnings Estimate Trends

At Zacks, the primary focus is on changes in earnings forecasts, as a stock’s true value is closely tied to the present value of its expected future profits.

The analysis centers on how Wall Street analysts are updating their earnings projections in response to new business developments. When these estimates rise, the stock’s fair value typically increases, often attracting buyers and pushing the price higher. Research consistently shows a strong link between earnings estimate revisions and short-term stock price movements.

Currently, Eli Lilly is projected to earn $7.35 per share this quarter, a 120.1% increase from the same period last year. Over the past month, the consensus estimate has climbed by 5.7%.

For the full fiscal year, analysts expect earnings of $33.86 per share, up 39.9% year over year, with this estimate rising 4.4% in the last 30 days.

Looking ahead to the next fiscal year, the consensus estimate stands at $42.18 per share, a 24.6% increase from the prior year, and up 1.7% over the past month.

With a proven track record verified by external audits, the Zacks Rank system leverages these earnings estimate changes to provide a clear view of a stock’s likely direction. Given the recent upward revisions and other related factors, Lilly currently holds a Zacks Rank #3 (Hold).

The following chart illustrates the progression of the company’s forward 12-month consensus EPS estimate:

12-Month EPS Estimate Trend

Revenue Growth Projections

While earnings growth is a key measure of financial strength, sustained profit increases are rarely possible without expanding revenue. Understanding a company’s revenue growth potential is therefore essential.

For the current quarter, Lilly’s consensus sales estimate is $17.66 billion, reflecting a 38.8% year-over-year increase. For the current and next fiscal years, projected revenues are $81.93 billion and $93.94 billion, representing growth rates of 25.7% and 14.7%, respectively.

Recent Results and Earnings Surprises

In its latest quarter, Lilly reported revenue of $19.29 billion, a 42.6% jump from the previous year. Earnings per share reached $7.54, up from $5.32 a year earlier.

These results exceeded the Zacks Consensus Estimate of $17.87 billion in revenue by 7.95%, and the EPS estimate by 7.87%.

Over the past four quarters, Lilly has beaten consensus EPS estimates three times and surpassed revenue expectations in each quarter.

Valuation Overview

Assessing a stock’s valuation is crucial for making informed investment choices. Comparing current valuation ratios—such as price-to-earnings, price-to-sales, and price-to-cash flow—to historical averages and industry peers helps determine whether a stock is fairly priced, overvalued, or undervalued.

The Zacks Value Style Score, which evaluates both conventional and alternative valuation metrics, grades stocks from A (best) to F (worst). This system helps investors identify stocks that may be mispriced.

Currently, Lilly receives a C grade, suggesting its valuation is in line with industry peers.

Summary

The information presented here, along with additional resources on Zacks.com, can help investors decide whether to pay attention to the current market interest in Lilly. However, with a Zacks Rank #3, the stock is expected to perform similarly to the broader market in the near term.

The Next Phase of AI Investing

The artificial intelligence boom has already created significant wealth, but the most well-known stocks may not offer the largest gains going forward. Lesser-known AI companies addressing major global challenges could present more attractive opportunities in the months and years ahead.